This Ex Parte Appeal was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on June 14, 2022 and assigned serial number 79300658 by the TTAB.

Plaintiff:
Glycostem Therapeutics B.V. represented by MICHAEL M. MORRIS of WOODARD EMHARDT HENRY REEVES & WAGNER.
Trademark Information: VIVENK – US Trademark Serial Number 79300658
View Trademark Status at USPTO
View Trademark Documents at USPTO

********

Prosecution History:
June 14, 2022 – APPEAL TO BOARD
June 14, 2022 – APPEAL ACKNOWLEDGED; CASE REMANDED
June 14, 2022 – INSTITUTED
July 12, 2022 – RECON DENIED
July 26, 2022 – PROCEEDINGS RESUMED
September 12, 2022 – FIRST REQ TO EXT TIME TO FILE MAIN BRIEF
September 13, 2022 – FIRST REQ TO EXT TIME TO FILE MAIN BRIEF GRANTED
November 22, 2022 – ADD’L REQ TO EXT TIME TO FILE MAIN BRIEF
November 22, 2022 – ADD’L REQ TO EXT TIME TO FILE MAIN BRIEF GRANTED
January 21, 2023 – APPELLANT MOT TO SUSPEND
January 23, 2023 – SUSPENDED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.